Therriault et al. conducted a prospective study using amyloid positron emission tomography (PET) and tau PET to evaluate the prevalence of biologically defined AD in relation to age, sex, serum markers, and clinical diagnosis [3]. Here, MAPT is linked to Alzheimer disease.